Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.
Verrou E, Papageorgiou SG, Bouzani M, Sevastoudi A, Triantafyllou T, Daiou A, Dalampira D, Arapaki M, Giatra C, Banti A, Kyriakidis G, Stoumpos D, Karampatzakis N, Papadopoulou T, Kotsopoulou M, Pouli A, Mandala E, Pappa V, Spanoudakis E, Katodritou E, Vassilakopoulos TP. Verrou E, et al. Among authors: triantafyllou t. Hematol Oncol. 2024 Sep;42(5):e3303. doi: 10.1002/hon.3303. Hematol Oncol. 2024. PMID: 39105590
Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: correlations with treatment outcome.
Hadjiaggelidou C, Mandala E, Terpos E, Yiannaki E, Markala D, Triantafyllou T, Papatheodorou A, Gkastari V, Verrou E, Papanikolaou A, Konstantinidou P, Katodritou E. Hadjiaggelidou C, et al. Among authors: triantafyllou t. Ann Hematol. 2019 Jun;98(6):1457-1466. doi: 10.1007/s00277-019-03657-3. Epub 2019 Mar 20. Ann Hematol. 2019. PMID: 30895351
Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working group.
Katodritou E, Kastritis E, Gatt M, Cohen YC, Avivi I, Pouli A, Lalayianni C, Lavi N, Delimpasis S, Kyrtsonis MC, Michael M, Suriu C, Miri Z, Tzafarti K, Vadikoliou C, Maltezas D, Zikos P, Ganzel C, Vaxman Y, Aviv A, Christoforidou A, Gavriatopoulou M, Shaulov A, Verrou E, Papanota AM, Fakinos G, Gkioka AI, Palaska V, Triantafyllou T, Konstantinidou P, Anagnostopoulos A, Terpos E, Dimopoulos MA. Katodritou E, et al. Among authors: triantafyllou t. Am J Hematol. 2020 May;95(5):465-471. doi: 10.1002/ajh.25755. Epub 2020 Mar 2. Am J Hematol. 2020. PMID: 32048329 Free article.
A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy.
Paschali A, Panagiotidis E, Triantafyllou T, Palaska V, Tsirou K, Verrou E, Υiannaki E, Markala D, Papanikolaou A, Pouli A, Konstantinidou P, Chatzipavlidou V, Terpos E, Katodritou E. Paschali A, et al. Among authors: triantafyllou t. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1487-1497. doi: 10.1007/s00259-020-05078-1. Epub 2020 Oct 25. Eur J Nucl Med Mol Imaging. 2021. PMID: 33099659
Visceral Leishmaniasis in 2 Patients Treated With Lenalidomide and Dexamethasone: A Possible Correlation With Blunted Immune Response.
Hadjiaggelidou C, Vadikolia C, Verrou E, Yiannaki E, Triantafyllou T, Palaska V, Keramidioti K, Tsirou K, Papanikolaou A, Markala D, Konstantinidou P, Katodritou E. Hadjiaggelidou C, et al. Among authors: triantafyllou t. Hemasphere. 2020 Dec 9;5(1):e506. doi: 10.1097/HS9.0000000000000506. eCollection 2021 Jan. Hemasphere. 2020. PMID: 33324952 Free PMC article. No abstract available.
Characteristics and outcome of multiple myeloma patients presenting with anaemia only: A retrospective multi-centre study.
Shragai T, Gatt ME, Shaulov A, Katodritou E, Triantafyllou T, Lavi N, Pouli A, Sioni A, Vaxman I, Zektser M, Ganzel C, Benyamini N, Trestman S, Ziv-Baran T, Adam Y, Cohen YC, Avivi I. Shragai T, et al. Among authors: triantafyllou t. Leuk Res. 2021 Feb;101:106498. doi: 10.1016/j.leukres.2020.106498. Epub 2020 Dec 31. Leuk Res. 2021. PMID: 33453475 Clinical Trial.
Chromosome 1q21 aberrations identify ultra high-risk myeloma with prognostic and clinical implications.
Kastritis E, Migkou M, Dalampira D, Gavriatopoulou M, Fotiou D, Roussou M, Kanellias N, Ntanasis-Stathopoulos I, Malandrakis P, Theodorakakou F, Sevastoudi A, Eleutherakis-Papaiakovou E, Triantafyllou T, Terpos E, Katodritou E, Dimopoulos MA. Kastritis E, et al. Among authors: triantafyllou t. Am J Hematol. 2022 Sep;97(9):1142-1149. doi: 10.1002/ajh.26639. Epub 2022 Jun 29. Am J Hematol. 2022. PMID: 35731917 Free article.
Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls.
Gavriilaki E, Dalampira D, Theodorakakou F, Liacos CI, Kanellias N, Eleutherakis-Papaiakovou E, Terpos E, Gavriatopoulou M, Verrou E, Triantafyllou T, Sevastoudi A, Koravou EE, Touloumenidou T, Varelas C, Papalexandri A, Sakellari I, Dimopoulos MA, Kastritis E, Katodritou E. Gavriilaki E, et al. Among authors: triantafyllou t. J Clin Med. 2022 Jun 10;11(12):3355. doi: 10.3390/jcm11123355. J Clin Med. 2022. PMID: 35743426 Free PMC article.
95 results